Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

Clinical trial NCT07287397 · RECRUITING

Trial details

NCT number: NCT07287397
Sponsor: Vector Y Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2025-12-19
Primary completion: 2027-10-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.